Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03353675
Title A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Transgene
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | HUN | FRA | BEL

Facility Status City State Zip Country Details
Charlotte Charlotte North Carolina 28204 United States Details
Nashville Nashville Tennessee 37203 United States Details
Libramont Libramont Belgium Details
Créteil Créteil France Details
Mulhouse Mulhouse France Details
Rennes Rennes France Details
Strasbourg Strasbourg France Details
Budapest Budapest Hungary Details
Szekesfehervar Szekesfehervar Hungary Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field